Clinical trial of levamisole in the treatment of ascariasis in Khorasan, Iran.

Abstract

This paper identifies the parasitic infections and their incidence in 246 people aged between 10--20 years living in a semi-rural Iranian village. 64 patients with ascariasis were treated with levamisole ('Ketrax' ICI) in accordance with the manufacturer's instructions. Most were followed up 1 and 2 weeks after treatment, with cure rate of 97.7% and 98.4% respectively, as assessed by negative egg findings in faeces. No side effects were reported. Levamisole meets the requirements of individual and mass treatment of ascariasis.

• Authors: H F Nagaty, M Mohajeri, R Elahi
• Journal: The Journal of tropical medicine and hygiene (J Trop Med Hyg) Vol. 81 Issue 10 Pg. 195-7 (Oct 1978) ISSN: 0022-5304 [Print] England
• PMID: 731761 (Publication Type: Journal Article)

Chemical References

• Levamisole

Topics

• Adolescent
• Adult
• Ascariasis (drug therapy, epidemiology)
• Child
• Child, Preschool
• Female
• Humans
• Intestinal Diseases, Parasitic (drug therapy, epidemiology)
• Iran
• Levamisole (administration & dosage, therapeutic use)
• Male